教授/主任医师，领军人才 &“国家杰青”获得者
西安交通大学第一附属医院心血管病医院院长
中华医学会心血管病分会常委兼动脉粥样硬化与冠心病学组组长
中国医师协会心血管内科医师分会副会长兼指南与共识工作组组长
中国老年医学会心血管病分会副主任委员
国际动脉粥样学会（IAS）中国分会副主席
陕西省医学会心血管病分会主任委员
中国胸痛中心联盟副主席/陕西省胸痛中心联盟主席
陕西省心血管专科医师联盟主席
中国动脉粥样硬化杂志副主编
中国分子心脏病学杂志副主编
中国介入心脏病学杂志副主编
主要从事动脉粥样硬化发生与发展机制研究、以及冠心病发病的基础与临床研究，先后承担（首席）国家科技部“973”项目和科技部重点研发项目、完成国科金重点与杰青项目、科技部重大慢病管理项目等，在国际顶级刊物包括Nature Medicine, Circulation, JACC, Cir Res, Euro Heart J, AJRCC等发表论文300余篇，获卫生部有突出贡献专家称号，享受国务院政府津贴
Videos：0
Abstracts：13
3455
0
0
| Date | Time | Local Time | Room | Session | Role | Topic |
|---|---|---|---|---|---|---|
| 2020-10-19 | 09:36-09:51 | 2020-10-19,09:36-09:51 | Clinical Coronary Artery Disease Channel |
Basic Research of Coronary Artery Disease 【Atherosclerosis and Coronary Artery Disease Forum】 |
Speaker | MiR-483-PCSK9 Pathway and Its Role in Atherosclerosis |
| 2020-10-20 | 09:20-09:40 | 2020-10-20,09:20-09:40 | Interpretation of Clinical Research and Guideline Channel |
CHD：Guideline Interpretation & Clinical Implication |
Speaker | Interpretation of Most Recent STEMI Guidelines |
| 2020-10-20 | 11:22-11:37 | 2020-10-20,11:22-11:37 | Clinical Coronary Artery Disease Channel |
Management of Dyslipidemia in Coronary Artery Disease 【Atherosclerosis and Coronary Artery Disease Forum】 |
Speaker | Interpretation of Chinese Expert Consensus on the Management of Blood Lipids in Very-High-Risk ASCVD Patients |
| 2020-10-20 | 12:30-13:30 | 2020-10-20,12:30-13:30 | PCI Optimization Channel |
【Satellite Symposium】Ultratimes NC Balloon Satellite Symposium and Launch Meeting |
Moderator | |
| 2020-10-20 | 12:31-12:32 | 2020-10-20,12:31-12:32 | PCI Optimization Channel |
【Satellite Symposium】Ultratimes NC Balloon Satellite Symposium and Launch Meeting |
Speaker | Opening Video & Speech |
| 2020-10-20 | 15:06-15:21 | 2020-10-20,15:06-15:21 | Prevention and Rehabilitation Channel |
Lipid Management Strategies in Different Populations |
Speaker | Lipid Management Strategies for ASCVD Patients with Extremely High Risk |
| 2020-10-20 | 16:30-16:45 | 2020-10-20,16:30-16:45 | Heart Failure and Cardiomyopathy Channel |
The Newest Development in SGLT2 Inhibitor and Heart Failure |
Speaker | SGLT2 Inhibitor and Heart Failure |
| 2020-10-21 | 17:30-18:30 | 2020-10-21,17:30-18:30 | Atrial Fibrillation Channel |
【Satellite Symposium】Boehringer Ingelheim Satellite Symposium: Debate on the Clinical Value of NOAC Reversal Agents |
Moderator | |
| 2020-10-22 | 19:00-21:00 | 2020-10-22,19:00-21:00 | Asia Cooperation Channel |
CGCF @ GW-ICC: Summit of LAA Closure 2020 |
Moderator | |
| 2020-10-23 | 09:00-12:00 | 2020-10-23,09:00-12:00 | CTO Week Channel |
Session 1 |
Moderator | |
| 2020-10-23 | 12:30-13:30 | 2020-10-23,12:30-13:30 | Clinical Coronary Artery Disease Channel |
【Satellite Symposium】CHUGAI Noon Satellite Symposium【Metabolic Disease and Cardiovascular Disease Forum】 |
Moderator | |
| 2020-10-24 | 09:00-10:30 | 2020-10-24,09:00-10:30 | Clinical Coronary Artery Disease Channel |
【Symposium】AZ Symposium: Drug Management of Acute Coronary Syndrome 【Acute Coronary Syndrome Forum】 |
Moderator | |
| 2020-10-24 | 11:00-11:02 | 2020-10-24,11:00-11:02 | Clinical Coronary Artery Disease Channel |
【Symposium】 Amgen Symposium【Acute Coronary Syndrome Forum】 |
Discussant | Opening |
| 2020-10-24 | 11:00-12:30 | 2020-10-24,11:00-12:30 | Clinical Coronary Artery Disease Channel |
【Symposium】 Amgen Symposium【Acute Coronary Syndrome Forum】 |
Moderator | |
| 2020-10-24 | 12:22-12:30 | 2020-10-24,12:22-12:30 | Clinical Coronary Artery Disease Channel |
【Symposium】 Amgen Symposium【Acute Coronary Syndrome Forum】 |
Discussant | Discussion |
| 2020-10-25 | 11:00-12:30 | 2020-10-25,11:00-12:30 | Clinical Coronary Artery Disease Channel |
Interpretation of Guideline & Consensus on Acute Chest Pain |
Moderator |